Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX STOCKHOLM  >  Episurf Medical AB (publ)    EPIS B   SE0003491562

EPISURF MEDICAL AB (PUBL)

(EPIS B)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

Episurf Medical : First Episealer® surgery performed in the US

10/01/2020 | 03:21am EST

Episurf Medical (NASDAQ: EPIS B) today announces that the first Episealer® surgery in the US was performed yesterday. The surgery was performed by Dr. Doug Haltom, MD at the West Tennessee Bone & Joint Clinic in Jackson, Tennessee (Clinical Research Solutions, Jackson, TN), within the company's IDE Clinical Trial, EPIC-Knee: Episealer® Knee System IDE Clinical Study.

"The procedure went great today. Instrumentation worked extremely well. Excited about the future of this product and procedure" says Dr. Doug Haltom.

"This is, of course, a great milestone for us, and we would like to extend our gratitude to everyone involved. Many more surgeries are to come in the US, but the first surgery in the US is a special milestone for us", says Pål Ryfors, CEO Episurf Medical.

For more information, please contact:

Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com
About Episurf Medical

Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical's Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical's μiFidelity® system enables implants to be cost-efficiently tailored to each individual's unique injury for the optimal fit and minimal intervention. Episurf Medical's head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company's website: www.episurf.com.

https://news.cision.com/episurf/r/first-episealer--surgery-performed-in-the-us,c3208507

https://mb.cision.com/Main/14691/3208507/1313517.pdf

(c) 2020 Cision. All rights reserved., source Press Releases - English

All news about EPISURF MEDICAL AB (PUBL)
11/30EPISURF MEDICAL : Episealer® presentation at the Combined Bristol & Oxford Unico..
AQ
11/27EPISURF MEDICAL : enters into international advisory agreement
AQ
11/26EPISURF MEDICAL : carries out a directed share issue and raises proceeds of SEK ..
AQ
11/13EPISURF MEDICAL : First Episealer® surgery in Scotland performed
AQ
11/04EPISURF MEDICAL : First Episealer® Talus surgery in Scandinavia performed
AQ
10/26DNB MARKETS - EPISURF MEDICAL :  Clinical data strengthens the case
AQ
10/26EPISURF MEDICAL : First Episealer® surgery performed in Asia
AQ
10/23EPISURF MEDICAL : Interim Report 1 July - 30 September 2020
AQ
10/15EPISURF MEDICAL : enters into a distribution agreement for additional markets in..
AQ
10/14EPISURF MEDICAL : Members of the Nomination Committee for Episurf Medical's Annu..
AQ
More news
Financials
Sales 2020 6,00 M 0,70 M 0,70 M
Net income 2020 -72,8 M -8,51 M -8,51 M
Net cash 2020 81,0 M 9,47 M 9,47 M
P/E ratio 2020 -5,87x
Yield 2020 -
Capitalization 434 M 50,7 M 50,7 M
EV / Sales 2020 58,9x
EV / Sales 2021 36,4x
Nbr of Employees 25
Free-Float 89,1%
Chart EPISURF MEDICAL AB (PUBL)
Duration : Period :
Episurf Medical AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EPISURF MEDICAL AB (PUBL)
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts 2
Average target price 4,00 SEK
Last Close Price 2,35 SEK
Spread / Highest target 70,6%
Spread / Average Target 70,6%
Spread / Lowest Target 70,6%
EPS Revisions
Managers
NameTitle
Pål Ryfors Chief Executive Officer
Dennis D. Stripe Chairman
Katarina Flodstrom Chief Operating & Regulatory Officer
Veronica Wallin Chief Financial Officer
Leif Erik Sigfrid Ryd Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
EPISURF MEDICAL AB (PUBL)100.43%51
STRYKER CORPORATION11.17%87 710
SMITH & NEPHEW PLC-20.82%16 917
INSPIRE MEDICAL SYSTEMS, INC.150.29%5 003
VENUS MEDTECH (HANGZHOU) INC.81.87%3 866
GLAUKOS CORPORATION23.88%3 032